Global Opioid Use Disorder Market Insights and Forecast to 2028

Report ID: 1530477 | Published Date: Mar 2026 | No. of Page: 96 | Base Year: 2025 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Opioid Use Disorder Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Buprenorphine
        1.2.3 Methadone
        1.2.4 Naltrexone
    1.3 Market by Application
        1.3.1 Global Opioid Use Disorder Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Moderate Pain Treatment
        1.3.3 Severe Pain Treatment
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Opioid Use Disorder Market Perspective (2017-2028)
    2.2 Opioid Use Disorder Growth Trends by Region
        2.2.1 Opioid Use Disorder Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Opioid Use Disorder Historic Market Size by Region (2017-2022)
        2.2.3 Opioid Use Disorder Forecasted Market Size by Region (2023-2028)
    2.3 Opioid Use Disorder Market Dynamics
        2.3.1 Opioid Use Disorder Industry Trends
        2.3.2 Opioid Use Disorder Market Drivers
        2.3.3 Opioid Use Disorder Market Challenges
        2.3.4 Opioid Use Disorder Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Opioid Use Disorder Players by Revenue
        3.1.1 Global Top Opioid Use Disorder Players by Revenue (2017-2022)
        3.1.2 Global Opioid Use Disorder Revenue Market Share by Players (2017-2022)
    3.2 Global Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Opioid Use Disorder Revenue
    3.4 Global Opioid Use Disorder Market Concentration Ratio
        3.4.1 Global Opioid Use Disorder Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Opioid Use Disorder Revenue in 2021
    3.5 Opioid Use Disorder Key Players Head office and Area Served
    3.6 Key Players Opioid Use Disorder Product Solution and Service
    3.7 Date of Enter into Opioid Use Disorder Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Use Disorder Breakdown Data by Type
    4.1 Global Opioid Use Disorder Historic Market Size by Type (2017-2022)
    4.2 Global Opioid Use Disorder Forecasted Market Size by Type (2023-2028)
5 Opioid Use Disorder Breakdown Data by Application
    5.1 Global Opioid Use Disorder Historic Market Size by Application (2017-2022)
    5.2 Global Opioid Use Disorder Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Opioid Use Disorder Market Size (2017-2028)
    6.2 North America Opioid Use Disorder Market Size by Type
        6.2.1 North America Opioid Use Disorder Market Size by Type (2017-2022)
        6.2.2 North America Opioid Use Disorder Market Size by Type (2023-2028)
        6.2.3 North America Opioid Use Disorder Market Share by Type (2017-2028)
    6.3 North America Opioid Use Disorder Market Size by Application
        6.3.1 North America Opioid Use Disorder Market Size by Application (2017-2022)
        6.3.2 North America Opioid Use Disorder Market Size by Application (2023-2028)
        6.3.3 North America Opioid Use Disorder Market Share by Application (2017-2028)
    6.4 North America Opioid Use Disorder Market Size by Country
        6.4.1 North America Opioid Use Disorder Market Size by Country (2017-2022)
        6.4.2 North America Opioid Use Disorder Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Opioid Use Disorder Market Size (2017-2028)
    7.2 Europe Opioid Use Disorder Market Size by Type
        7.2.1 Europe Opioid Use Disorder Market Size by Type (2017-2022)
        7.2.2 Europe Opioid Use Disorder Market Size by Type (2023-2028)
        7.2.3 Europe Opioid Use Disorder Market Share by Type (2017-2028)
    7.3 Europe Opioid Use Disorder Market Size by Application
        7.3.1 Europe Opioid Use Disorder Market Size by Application (2017-2022)
        7.3.2 Europe Opioid Use Disorder Market Size by Application (2023-2028)
        7.3.3 Europe Opioid Use Disorder Market Share by Application (2017-2028)
    7.4 Europe Opioid Use Disorder Market Size by Country
        7.4.1 Europe Opioid Use Disorder Market Size by Country (2017-2022)
        7.4.2 Europe Opioid Use Disorder Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Opioid Use Disorder Market Size (2017-2028)
    8.2 Asia-Pacific Opioid Use Disorder Market Size by Type
        8.2.1 Asia-Pacific Opioid Use Disorder Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Opioid Use Disorder Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Opioid Use Disorder Market Share by Type (2017-2028)
    8.3 Asia-Pacific Opioid Use Disorder Market Size by Application
        8.3.1 Asia-Pacific Opioid Use Disorder Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Opioid Use Disorder Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Opioid Use Disorder Market Share by Application (2017-2028)
    8.4 Asia-Pacific Opioid Use Disorder Market Size by Region
        8.4.1 Asia-Pacific Opioid Use Disorder Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Opioid Use Disorder Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Opioid Use Disorder Market Size (2017-2028)
    9.2 Latin America Opioid Use Disorder Market Size by Type
        9.2.1 Latin America Opioid Use Disorder Market Size by Type (2017-2022)
        9.2.2 Latin America Opioid Use Disorder Market Size by Type (2023-2028)
        9.2.3 Latin America Opioid Use Disorder Market Share by Type (2017-2028)
    9.3 Latin America Opioid Use Disorder Market Size by Application
        9.3.1 Latin America Opioid Use Disorder Market Size by Application (2017-2022)
        9.3.2 Latin America Opioid Use Disorder Market Size by Application (2023-2028)
        9.3.3 Latin America Opioid Use Disorder Market Share by Application (2017-2028)
    9.4 Latin America Opioid Use Disorder Market Size by Country
        9.4.1 Latin America Opioid Use Disorder Market Size by Country (2017-2022)
        9.4.2 Latin America Opioid Use Disorder Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Opioid Use Disorder Market Size (2017-2028)
    10.2 Middle East & Africa Opioid Use Disorder Market Size by Type
        10.2.1 Middle East & Africa Opioid Use Disorder Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Opioid Use Disorder Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Opioid Use Disorder Market Share by Type (2017-2028)
    10.3 Middle East & Africa Opioid Use Disorder Market Size by Application
        10.3.1 Middle East & Africa Opioid Use Disorder Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Opioid Use Disorder Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Opioid Use Disorder Market Share by Application (2017-2028)
    10.4 Middle East & Africa Opioid Use Disorder Market Size by Country
        10.4.1 Middle East & Africa Opioid Use Disorder Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Opioid Use Disorder Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Indivior
        11.1.1 Indivior Company Details
        11.1.2 Indivior Business Overview
        11.1.3 Indivior Opioid Use Disorder Introduction
        11.1.4 Indivior Revenue in Opioid Use Disorder Business (2017-2022)
        11.1.5 Indivior Recent Developments
    11.2 Alkermes
        11.2.1 Alkermes Company Details
        11.2.2 Alkermes Business Overview
        11.2.3 Alkermes Opioid Use Disorder Introduction
        11.2.4 Alkermes Revenue in Opioid Use Disorder Business (2017-2022)
        11.2.5 Alkermes Recent Developments
    11.3 Titan Pharmaceuticals
        11.3.1 Titan Pharmaceuticals Company Details
        11.3.2 Titan Pharmaceuticals Business Overview
        11.3.3 Titan Pharmaceuticals Opioid Use Disorder Introduction
        11.3.4 Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022)
        11.3.5 Titan Pharmaceuticals Recent Developments
    11.4 Hikma Pharmaceuticals
        11.4.1 Hikma Pharmaceuticals Company Details
        11.4.2 Hikma Pharmaceuticals Business Overview
        11.4.3 Hikma Pharmaceuticals Opioid Use Disorder Introduction
        11.4.4 Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022)
        11.4.5 Hikma Pharmaceuticals Recent Developments
    11.5 Teva Pharmaceuticals
        11.5.1 Teva Pharmaceuticals Company Details
        11.5.2 Teva Pharmaceuticals Business Overview
        11.5.3 Teva Pharmaceuticals Opioid Use Disorder Introduction
        11.5.4 Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022)
        11.5.5 Teva Pharmaceuticals Recent Developments
    11.6 MediciNova
        11.6.1 MediciNova Company Details
        11.6.2 MediciNova Business Overview
        11.6.3 MediciNova Opioid Use Disorder Introduction
        11.6.4 MediciNova Revenue in Opioid Use Disorder Business (2017-2022)
        11.6.5 MediciNova Recent Developments
    11.7 Orexo
        11.7.1 Orexo Company Details
        11.7.2 Orexo Business Overview
        11.7.3 Orexo Opioid Use Disorder Introduction
        11.7.4 Orexo Revenue in Opioid Use Disorder Business (2017-2022)
        11.7.5 Orexo Recent Developments
    11.8 Camurus
        11.8.1 Camurus Company Details
        11.8.2 Camurus Business Overview
        11.8.3 Camurus Opioid Use Disorder Introduction
        11.8.4 Camurus Revenue in Opioid Use Disorder Business (2017-2022)
        11.8.5 Camurus Recent Developments
    11.9 Omeros
        11.9.1 Omeros Company Details
        11.9.2 Omeros Business Overview
        11.9.3 Omeros Opioid Use Disorder Introduction
        11.9.4 Omeros Revenue in Opioid Use Disorder Business (2017-2022)
        11.9.5 Omeros Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Opioid Use Disorder Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Buprenorphine
    Table 3. Key Players of Methadone
    Table 4. Key Players of Naltrexone
    Table 5. Global Opioid Use Disorder Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Opioid Use Disorder Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Opioid Use Disorder Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Opioid Use Disorder Market Share by Region (2017-2022)
    Table 9. Global Opioid Use Disorder Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Opioid Use Disorder Market Share by Region (2023-2028)
    Table 11. Opioid Use Disorder Market Trends
    Table 12. Opioid Use Disorder Market Drivers
    Table 13. Opioid Use Disorder Market Challenges
    Table 14. Opioid Use Disorder Market Restraints
    Table 15. Global Opioid Use Disorder Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Opioid Use Disorder Revenue Share by Players (2017-2022)
    Table 17. Global Top Opioid Use Disorder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2021)
    Table 18. Ranking of Global Top Opioid Use Disorder Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Opioid Use Disorder Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Opioid Use Disorder Product Solution and Service
    Table 22. Date of Enter into Opioid Use Disorder Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Opioid Use Disorder Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Opioid Use Disorder Revenue Market Share by Type (2017-2022)
    Table 26. Global Opioid Use Disorder Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Opioid Use Disorder Revenue Market Share by Type (2023-2028)
    Table 28. Global Opioid Use Disorder Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Opioid Use Disorder Revenue Share by Application (2017-2022)
    Table 30. Global Opioid Use Disorder Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Opioid Use Disorder Revenue Share by Application (2023-2028)
    Table 32. North America Opioid Use Disorder Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Opioid Use Disorder Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Opioid Use Disorder Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Opioid Use Disorder Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Opioid Use Disorder Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Opioid Use Disorder Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Opioid Use Disorder Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Opioid Use Disorder Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Opioid Use Disorder Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Opioid Use Disorder Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Opioid Use Disorder Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Opioid Use Disorder Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Opioid Use Disorder Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Opioid Use Disorder Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Opioid Use Disorder Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Opioid Use Disorder Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Opioid Use Disorder Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Opioid Use Disorder Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Opioid Use Disorder Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Opioid Use Disorder Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Opioid Use Disorder Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Opioid Use Disorder Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Opioid Use Disorder Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Opioid Use Disorder Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Opioid Use Disorder Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Opioid Use Disorder Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Opioid Use Disorder Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Opioid Use Disorder Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Opioid Use Disorder Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Opioid Use Disorder Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Indivior Company Details
    Table 63. Indivior Business Overview
    Table 64. Indivior Opioid Use Disorder Product
    Table 65. Indivior Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
    Table 66. Indivior Recent Developments
    Table 67. Alkermes Company Details
    Table 68. Alkermes Business Overview
    Table 69. Alkermes Opioid Use Disorder Product
    Table 70. Alkermes Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
    Table 71. Alkermes Recent Developments
    Table 72. Titan Pharmaceuticals Company Details
    Table 73. Titan Pharmaceuticals Business Overview
    Table 74. Titan Pharmaceuticals Opioid Use Disorder Product
    Table 75. Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
    Table 76. Titan Pharmaceuticals Recent Developments
    Table 77. Hikma Pharmaceuticals Company Details
    Table 78. Hikma Pharmaceuticals Business Overview
    Table 79. Hikma Pharmaceuticals Opioid Use Disorder Product
    Table 80. Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
    Table 81. Hikma Pharmaceuticals Recent Developments
    Table 82. Teva Pharmaceuticals Company Details
    Table 83. Teva Pharmaceuticals Business Overview
    Table 84. Teva Pharmaceuticals Opioid Use Disorder Product
    Table 85. Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
    Table 86. Teva Pharmaceuticals Recent Developments
    Table 87. MediciNova Company Details
    Table 88. MediciNova Business Overview
    Table 89. MediciNova Opioid Use Disorder Product
    Table 90. MediciNova Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
    Table 91. MediciNova Recent Developments
    Table 92. Orexo Company Details
    Table 93. Orexo Business Overview
    Table 94. Orexo Opioid Use Disorder Product
    Table 95. Orexo Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
    Table 96. Orexo Recent Developments
    Table 97. Camurus Company Details
    Table 98. Camurus Business Overview
    Table 99. Camurus Opioid Use Disorder Product
    Table 100. Camurus Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
    Table 101. Camurus Recent Developments
    Table 102. Omeros Company Details
    Table 103. Omeros Business Overview
    Table 104. Omeros Opioid Use Disorder Product
    Table 105. Omeros Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
    Table 106. Omeros Recent Developments
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Opioid Use Disorder Market Share by Type: 2021 VS 2028
    Figure 2. Buprenorphine Features
    Figure 3. Methadone Features
    Figure 4. Naltrexone Features
    Figure 5. Global Opioid Use Disorder Market Share by Application: 2021 VS 2028
    Figure 6. Moderate Pain Treatment Case Studies
    Figure 7. Severe Pain Treatment Case Studies
    Figure 8. Opioid Use Disorder Report Years Considered
    Figure 9. Global Opioid Use Disorder Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Opioid Use Disorder Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Opioid Use Disorder Market Share by Region: 2021 VS 2028
    Figure 12. Global Opioid Use Disorder Market Share by Players in 2021
    Figure 13. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Opioid Use Disorder Revenue in 2021
    Figure 15. North America Opioid Use Disorder Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Opioid Use Disorder Market Size Market Share by Type (2017-2028)
    Figure 17. North America Opioid Use Disorder Market Size Market Share by Application (2017-2028)
    Figure 18. North America Opioid Use Disorder Market Size Share by Country (2017-2028)
    Figure 19. United States Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Opioid Use Disorder Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Opioid Use Disorder Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Opioid Use Disorder Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Opioid Use Disorder Market Size Share by Country (2017-2028)
    Figure 25. Germany Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Opioid Use Disorder Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Opioid Use Disorder Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Opioid Use Disorder Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Opioid Use Disorder Market Size Share by Region (2017-2028)
    Figure 35. China Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Opioid Use Disorder Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Opioid Use Disorder Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Opioid Use Disorder Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Opioid Use Disorder Market Size Share by Country (2017-2028)
    Figure 45. Mexico Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Opioid Use Disorder Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Opioid Use Disorder Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Opioid Use Disorder Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Opioid Use Disorder Market Size Share by Country (2017-2028)
    Figure 51. Turkey Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Indivior Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
    Figure 55. Alkermes Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
    Figure 56. Titan Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
    Figure 57. Hikma Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
    Figure 58. Teva Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
    Figure 59. MediciNova Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
    Figure 60. Orexo Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
    Figure 61. Camurus Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
    Figure 62. Omeros Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Indivior
Alkermes
Titan Pharmaceuticals
Hikma Pharmaceuticals
Teva Pharmaceuticals
MediciNova
Orexo
Camurus
Omeros
Frequently Asked Questions
Opioid Use Disorder report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Opioid Use Disorder report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Opioid Use Disorder report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Smart LED Lighting

Smart LED Lighting market is segmented by players, region (country), by Type and by Application.  ... Read More

Athleisure

Athleisure market is segmented by players, region (country), by Type and by Application. Players, ... Read More

Tinplate Packaging

Tinplate Packaging market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More